Our objectives
Based on AMFA
NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA.
The main application
is the engineering of recombinant proteins like antibodies or enzymes for better therapies.
Development
NanoMedSyn develops engineered therapeutics in-house and in partnership.